Humacyte's total assets for Q2 2024 were $138.28M, a decrease of -14.36% from the previous quarter. HUMA total liabilities were $166.57M for the fiscal quarter, a 23.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.